These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24657140)

  • 1. Formulation and evaluation of novel reverse microemulsions containing salmon calcitonin in hydrofluoroalkane propellants.
    Shan Z; Tan Y; Qin L; Li G; Pan X; Wang Z; Yu X; Wang Q; Wu C
    Int J Pharm; 2014 May; 466(1-2):390-9. PubMed ID: 24657140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse aqueous microemulsions in hydrofluoroalkane propellants and their aerosol characteristics.
    Selvam P; Bharatwaj B; Porcar L; da Rocha SR
    Int J Pharm; 2012 Jan; 422(1-2):428-35. PubMed ID: 22044539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse aqueous emulsions and microemulsions in HFA227 propellant stabilized by non-ionic ethoxylated amphiphiles.
    Chokshi U; Selvam P; Porcar L; da Rocha SR
    Int J Pharm; 2009 Mar; 369(1-2):176-84. PubMed ID: 19028557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin nanoparticles: stability and aerosolization from pressurized metered dose inhalers.
    Nyambura BK; Kellaway IW; Taylor KM
    Int J Pharm; 2009 Jun; 375(1-2):114-22. PubMed ID: 19481697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel propellant-driven inhalation formulations: engineering polar drug particles with surface-trapped hydrofluoroalkane-philes.
    Wu L; Al-Haydari M; da Rocha SR
    Eur J Pharm Sci; 2008 Feb; 33(2):146-58. PubMed ID: 18083015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro investigation of the effect of ambient humidity on regional delivered dose with solution and suspension MDIs.
    Shemirani FM; Hoe S; Lewis D; Church T; Vehring R; Finlay WH
    J Aerosol Med Pulm Drug Deliv; 2013 Aug; 26(4):215-22. PubMed ID: 23094687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability and aerosolization of pressurized metered dose inhalers containing thymopentin nanoparticles produced using a bottom-up process.
    Tan Y; Yang Z; Pan X; Chen M; Feng M; Wang L; Liu H; Shan Z; Wu C
    Int J Pharm; 2012 May; 427(2):385-92. PubMed ID: 22343132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of reduction of propellant mass fraction on the injection profile of metered dose inhalers.
    Ju D; Shrimpton J; Hearn A
    Int J Pharm; 2010 May; 391(1-2):221-9. PubMed ID: 20227471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuning aerosol particle size distribution of metered dose inhalers using cosolvents and surfactants.
    Saleem IY; Smyth HD
    Biomed Res Int; 2013; 2013():574310. PubMed ID: 23984381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel pMDI formulations for pulmonary delivery of proteins.
    Li HY; Seville PC
    Int J Pharm; 2010 Jan; 385(1-2):73-8. PubMed ID: 19854252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Core-shell particles for the dispersion of small polar drugs and biomolecules in hydrofluoroalkane propellants.
    Wu L; Bharatwaj B; Panyam J; da Rocha SR
    Pharm Res; 2008 Feb; 25(2):289-301. PubMed ID: 17943419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The processing of nanoparticles containing protein for suspension in hydrofluoroalkane propellants.
    Nyambura BK; Kellaway IW; Taylor KM
    Int J Pharm; 2009 May; 372(1-2):140-6. PubMed ID: 19429273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosslinked chitosan nanoparticle formulations for delivery from pressurized metered dose inhalers.
    Sharma K; Somavarapu S; Colombani A; Govind N; Taylor KM
    Eur J Pharm Biopharm; 2012 May; 81(1):74-81. PubMed ID: 22245573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of initial atomized droplet size on residual particle size from pressurized metered dose inhalers.
    Sheth P; Stein SW; Myrdal PB
    Int J Pharm; 2013 Oct; 455(1-2):57-65. PubMed ID: 23911912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
    Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
    Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers.
    Liao YH; Brown MB; Jones SA; Nazir T; Martin GP
    Int J Pharm; 2005 Nov; 304(1-2):29-39. PubMed ID: 16181753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swellable hydrogel particles for controlled release pulmonary administration using propellant-driven metered dose inhalers.
    Selvam P; El-Sherbiny IM; Smyth HD
    J Aerosol Med Pulm Drug Deliv; 2011 Feb; 24(1):25-34. PubMed ID: 20961166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moisture uptake and its influence on pressurized metered-dose inhalers.
    Williams RO; Hu C
    Pharm Dev Technol; 2000; 5(2):153-62. PubMed ID: 10810745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the aerosol velocity and spray duration of Respimat Soft Mist inhaler and pressurized metered dose inhalers.
    Hochrainer D; Hölz H; Kreher C; Scaffidi L; Spallek M; Wachtel H
    J Aerosol Med; 2005; 18(3):273-82. PubMed ID: 16181002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers.
    Smyth HD; Hickey AJ
    AAPS PharmSciTech; 2003; 4(3):E38. PubMed ID: 14621970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.